Latest stories on KLRA
Inhibikase Therapeutics appoints Kailera CMO Scott Wasserman to board
The Fly56 · neutralgeneral
Jefferies reiterates Buy on Kailera stock, cites obesity pipeline
Investing.com Analyst Ratings61 · neutralanalyst
Kailera Therapeutics announces positive results from several presentations
The Fly73 · bullishproduct/pr
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
GlobeNewswire63 · neutralproduct/pr
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
Business Insider63 · neutralproduct/pr
Kailera announces completion of enrollment in KaiNETIC Phase 3 program
The Fly63 · neutralproduct/pr
Kailera Therapeutics: Hold Due To Need For Progress On Weight Loss Differentiation
Seeking Alpha48 · neutralanalyst
Kailera Therapeutics: An Outside Biotech Bet For The Next GLP-1 Obesity Drug Approval
Seeking Alpha63 · neutralproduct/pr
Kailera Therapeutics to Participate in September Investor Conferences
GlobeNewswire56 · neutralgeneral
Kailera Therapeutics to Participate in September Investor Conferences
Business Insider56 · neutralgeneral
Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore
Yahoo Finance38 · neutralgeneral
Kailera Therapeutics, Inc. reports Q2 results
Seeking Alpha34 · bearishearnings
Kailera Therapeutics, Inc. (KLRA) files 8-K
SEC 8-K50 · neutralgeneral
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
Business Insider56 · neutralproduct/pr
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire56 · neutralearnings
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
Business Insider56 · neutralgeneral
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
Yahoo Finance73 · bullishproduct/pr
Kailera Therapeutics: A Second-Wave Obesity Platform With More Than One Way To Win
Seeking Alpha67 · bullishproduct/pr
Kailera's oral weight loss pill met its trial goal, but nausea hit 70% of patients
Quartz38 · neutralproduct/pr
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
Investors.com67 · bullishgeneral
Kailera falls after late-stage trial data for oral GLP-1 candidate
Seeking Alpha34 · bearishproduct/pr
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer | KLRA Stock News
StockTitan63 · neutralproduct/pr